SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000882796-06-000032
Filing Date
2006-05-18
Accepted
2006-05-18 16:00:49
Documents
1
Period of Report
2006-05-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc.html 4  
1 PRIMARY DOCUMENT doc.xml 4 3919
  Complete submission text file 0000882796-06-000032.txt   5699
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1220
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address AMGEN INC ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
SEIDENBERG BETH C (Reporting) CIK: 0001184592 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 06852196